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Abstract 
Objective: To explore the prevalence and contributing factors of lower oxygen 
saturation in Northern Norway and Northwest Russia.  
Methods: The descriptive cross-sectional study included 3833 respondents from 
Northwest Russia (3215) and Northern Norway (618). All men and women aged 40 
years or more, visiting general practitioners´ (GPs) offices were the subjects. A 
structured questionnaire, a digital handheld pulse oximeter for oxygen saturation 
(SpO2) and pulse, and physical examination were used for data collection. 
Independent sample t-test (continuous) and chi-square test (categorical) were used to 
find a significant difference in two groups. The association between independent 
variables and oxygen saturation was measured using logistic regression and was 
reported as odd ratio (OR) with 95% confidence interval (CI).  
Results: The prevalence of low SpO2 (<95%) was 4.4% in Northern Norway and 
3.0% in Northwest Russia. In men and women, it was found to be 4.9% and 2.2% 
respectively. A significant predictor of lower oxygen saturation in both genders was 
´other heart disease´. In men, severe breathlessness problem (OR = 3.6; 95% CI = 1.4-
9.2) and current smoking habit (OR = 3.5; 95% CI = 1.6-7.3) showed statistically 
significant association with lower oxygen saturation. In women, a significant 
predictor of lower oxygen saturation was chronic obstructive pulmonary diseases 
(COPD) (OR = 8.8; 95% CI = 4.2-18.8). 
Conclusion: The contributing factors of lower oxygen saturation are other heart 
diseases, COPD, severe breathlessness problem and smoking habit.  
Keywords: COPD, prevalence, pulse oximetry, oxygen saturation 
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1. Introduction 
1.1 Background  
Oxygen saturation is a term referring to the concentration of oxygen in the blood. 
It measures the percentage of haemoglobin binding sites in the bloodstream occupied 
by oxygen. SpO2 stands for peripheral capillary oxygen saturation; is an estimation of 
the oxygen saturation level (1). 
A SpO2 greater than 95% is considered normal and below 92% (at sea level) suggests 
hypoxemia (2).  Low SpO2 occurs due to hypoventilation, right-to-left shunts, reduced 
diffusion capacity, ventilation-perfusion mismatch, and reduced oxygen partial 
pressure in inspired air (3). Blood oxygen levels below 80% compromise the organ 
function, such as the brain and heart. Continued low oxygen levels lead to a 
respiratory or cardiac arrest and it needs to be addressed  promptly (4). 
Generally, to assess arterial oxyhemoglobin saturation an economical, non-invasive 
(5) hand-held (2) device; pulse oximetry is used. It is based on light absorbance of 
oxy- and deoxy-hemoglobin at 660 and 940 nm wavelengths (6). The accuracy of 
oximeters differs depending on how it is made, particularly at saturations below 70%. 
Finger probes compared to ear probes are found to have a significantly higher 
correlation with oxygen saturation. Furthermore, factors like deoxyhemoglobinemia, 
hypothermia, and skin pigmentation can decrease accuracy (7).  
Application of pulse oximetry in general practice  
Pulse oximetry is used to manage chronic obstructive pulmonary disease (COPD), acute 
exacerbations and a need for long-term oxygen therapy and grading the severity of asthma 
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attack. Furthermore, it is used to assess the severity and oxygen requirements for patients 
with community-acquired pneumonia (8). 
Additionally, the role of pulse oximetry is significant for patient assessment and 
monitoring in critical care, anesthesiology, and emergency departments (9). In 
emergency medicine, SpO2 can relate mortality (10, 11)  and is included in risk scores 
predicting prognosis together with other vital signs (12, 13). It rapidly detects changes 
in oxygen saturation thus, provides an early warning of hypoxemia (9, 14).  
The choice to initiate oxygen therapy in acute COPD exacerbations based on an 
oxygen saturation value <90% is considered another possible application for pulse 
oximetry in primary care (15). A SpO2 92% indicates hypoxemia and the values 
between 93% and 95% are regarded as lower than normal (2, 14). A SpO2 up to 95% 
has been found to predict hypoxia during exercise in COPD patients (16). Dutch 
family practice guideline for COPD recommends that in the case of an exacerbation 
of COPD, respiratory failure is unlikely to be present with an arterial oxyhemoglobin 
saturation measured by pulse oximetry SpO2 >92% (17). 
In a study by Giesen et al based on a retrospective medical record analysis of patients 
contacting family physicians (FPs) cooperative, the value of pulse oximetry was 
especially recognised for patients previously unknown to the FP who presented with 
acute medical problems (18). The occasions in which FPs in the United Kingdom 
(UK) most often use pulse oximetry is in patients who present with an exacerbation of 
COPD (19). Being a simple and valid screening test for systemic hypoxia (20), the use 
of pulse oximetry in general practice is suggested (21, 22). However, new guidelines 
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on the use of pulse oximetry are partly evidence-based and more research is 
accordingly required (2).  
Asthma, a disease of the airways (23), is characterised by recurrent attacks of 
breathlessness and wheezing (24). The recent report (2014) estimated asthma to be 
prevalent among 334 million people worldwide. (23). COPD describes chronic lung 
diseases and leads to the persistent blockage of airflow from the lungs. World Health 
Organisation (WHO) estimates by 2030, COPD will likely to be the third leading 
cause of death worldwide (24). 
Globally, COPD and asthma are common conditions observed in primary care; 
affecting more than 1 billion patients worldwide (2). The estimated prevalence in a 
population aged 40-69 years was 6.3% and 7.2% in COPD and asthma respectively  
(25). Although, asthma and COPD are two different and independent diseases, the 
range observed in clinical practice is complex, particularly in older people with 
factors of both diseases (26). 
Other important causes of morbidity and mortality among older adults in western 
society besides COPD are cardiovascular diseases (CVD) (2). The majority of patients 
with COPD and congestive heart failure (CHF) get their diagnosis and treatment in 
general practice usually based on clinical symptoms (primarily, dyspnea) and physical 
examination. COPD and CHF are linked with reduced oxygenation of arterial blood in 
the lungs and, thereby, with low arterial oxyhemoglobin saturation (27). 
In the developing world, COPD is understudied, underdiagnosed, and undertreated 
disorder (28, 29). In Russia, data available on the epidemiology of COPD is limited 
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and the prevalence is underestimated, as in the case in many other countries (28, 30). 
As per one of the population based studies in Krasnoyarsk region in Russia (2011), 
the true prevalence of COPD was estimated as approximately 21.2 per 1,000 which 
was two times more than the  estimates based on medical diagnosis statistics (31). The 
respiratory disease showed higher premature mortality in Russian Arctic but the 
problem in Russia is disregarded (32). 
In Norway, the annual incidence of COPD is 7 cases per 1000 adults (33). The 
prevalence of COPD among adults aged 40 years or more varies from 5 to 10% (34). 
The SpO2 levels ≤95% is associated with reduced lung function, dyspnea (27) and 
increased mortality in the Norwegian adult population (35).  
COPD and CHF are resource-demanding medical conditions due to the cost of long-
term treatment and frequent hospitalization and the expenses apt to increase in future. 
According to the Norwegian Directorate of Health, the prevalence of CHF is about 
0.3-2 % and increases with age up to 10% among adults aged 80 years or more (36). 
The treatment of patients with COPD in Norway was calculated to cost about 24 
billion Norwegian Kroner during the next 20 years and these expenses are related to 
disease exacerbations rate. In addition, the cost of treatment of COPD patients will be 
200% higher if the rate of disease exacerbations in Norway will be the same as in 
Sweden (37).  
Epidemiological data suggests long-term oxygen therapy (LTOT) delivered by 
oxygen concentrators in patients with severe hypoxic chronic COPD is under-
prescribed by General Practitioners (GPs) in England and Wales. Provision of a non-
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invasive measure of oxygenation likely to improve detection of hypoxic subjects and 
enhance appropriate setting (35). 
The information about low oxygen saturation and its association with mortality or 
morbidity in a general population is limited. In recent studies , the predictors for low 
oxygen saturation in an adult population were found to be increased body mass index 
(BMI) (either very high or very low), reduced lung function defined by forced 
expiratory volume in 1s (FEV1)% predicted (38), increasing age, gender male, 
smoking history - both smoking, former smoking and pack-years (former smoking 
often not significant when pack years included) (39), and history of cardiovascular 
disease (CVD). Those predictors were found  associated to predict increasing 
mortality in general adult population studies (3). 
During short-term respiratory compromise, pulse oximetry delivers a method for rapid 
assessment. In a patient with acute respiratory illness (example, influenza) or 
breathing difficulty (example, an asthma attack), SpO2 of 92% or less may indicate a 
need for oxygen supplementation. In addition, in the patients with acute respiratory 
infection, it helps to determine the severity of the illness and, in conjunction with 
other criteria, determining whether and how to refer patients for further treatment 
(40). Moreover, it is also helpful in diagnosing diabetic peripheral arterial disease 
(41), in screening for congenital heart disease in children (42) and in predicting 
mortality risk in patients with a pulmonary embolus (43). Hence, it can be a useful aid 
to clinical decision-making, nevertheless, it is not a substitute for a clinical assessment 
nor sufficient for diagnosis by itself (40). 
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Despite the wide range of potential functions of pulse oximetry, very little research 
has been reported about its usage. The limited data reported have shown that the pulse 
oximetry can be beneficial to patients with acute respiratory insufficiency (including 
acute asthma attacks) and in the follow-up of patients with chronic respiratory 
conditions (22). To shed more light on the practicality of pulse oximetry, the aim of 
this study was to study associations between low oxygen saturation level (SpO2 
≤95%) and the variables.  
1.1.1 Background of POMOR Project 
Data for this study was collected from the POMOR project (2012). 
The POMOR project was started in 2009 as a collaboration program in postgraduate 
education of general practitioners with the objective to exchange Norwegian 
experience in small group teaching with Russian colleagues. The project ended up in 
2014. 
The Pomor Project (2012) was financed by the Norwegian Ministry of Health and 
Care Services under the Northern Dimension Partnership in Public Health and Social 
Well-being. As a part of the scientific study in POMOR project, the data on pulse 
oximetry and its correlates were collected from the GP populations in Northern 
Norway and Russia (44). 
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1.2 Statement of Problem 
Primary care clinicians are the first point of contact for patients suffering from acute 
respiratory infections. These health care professionals need tools to help them 
evaluate, monitor, and decide when to refer patients with respiratory conditions (2). 
Arterial blood gas measurement, obtained by arterial puncture is the gold standard for 
measurement of oxygen saturation. But it is invasive, painful, time-consuming, costly, 
provides only intermittent information on patient status, and is impractical in most 
primary care settings (2). Pulse oximetry in other hand, is simple to use, and useful in 
triaging potentially hypoxic patients to determine which patients should have arterial 
blood gas measurements (40).  
Being non-invasive method of screening and when applied to all COPD patients seen 
in general practice can help reveal those fulfilling the criteria for long-term oxygen 
who would otherwise not be identified (35). Likewise, it is  an important tool to 
evaluate, and monitor pulmonary diseases (6) together with assessing the severity of 
their patient's condition (35) and can be used for the management of acute and chronic 
respiratory disease in  primary care. However, the research is limited (40).  
Worsening of pulmonary diseases is associated with a decrease in oxygen 
saturation (SpO2). Such a decrease in SpO2 and associated factors has not been 
previously evaluated in a general adult population (45). Pulse oximetry has been 
recommended for monitoring COPD patients, but the evidence for its usefulness is 
bare (2). The aim of this study is to describe the distribution of low pulse oximetry 
values in a general adult population and their association with certain predictors (45). 
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1.3 Rationale of the Study  
The low arterial oxyhemoglobin saturation is an objective proxy display of chronic 
respiratory failure and conditions like chronic heart failure and others, which a GP 
meets in his/her everyday practice. This knowledge is necessary for health authorities 
for planning health care in these groups of patients. Our study will be beneficial 
further to investigate the importance of using pulse oximetry in primary care 
settings. 
Moreover, this study will be useful in finding the associated factors of lower oxygen 
saturation among GP populations. It will be helpful to provide the evidence of the 
importance of usage of pulse oximetry in clinical settings thus encouraging the 
clinical areas to introduce pulse oximetry in the health settings as a normal procedure.  
In addition, this study can provide recommendations for the use of pulse oximetry in 
general practice for following-up the patients with chronic heart- or/and respiratory 
failure in Norway and Russia. Before introducing pulse oximetry in general practice 
on a larger scale in Norway and Russia, it is important to explore SpO2 distribution in 
subgroups of GP patients. 
This study can also be beneficial for other researchers to gain valuable information 
regarding the issue of interest. Besides, it can also be valuable to the organization 
working in pulse oximeter together with those working in the area of respiratory 
diseases and cardiovascular diseases.  
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1.4 Objectives of the Study: 
1.4.1. General Objectives 
To explore the factors associated with decreased oxygen saturation among GP 
populations of adults in Northern Norway and Northwest Russia. 
1.4.2 Specific Objective 
x To find the common factors associated with lower oxygen saturation among GP 
populations of adults in Northern Norway and Northwest Russia. 
x To compare the prevalence of lower oxygen saturation between Northern Norway 
and Northwest Russia. 
x To explore the significant association between gender and level of oxygen 
saturation. 
x To provide information to the centers concerned which will be helpful to 
implement the usage of pulse oximetry for general practitioners. 
1.5 Research Question/ Hypothesis 
What is the prevalence of lower oxygen saturation among GP populations of adults in 
Northern Norway and Northern Russia? 
What are the major factors associated with decreased oxygen saturation in GPs adult 
populations? 
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1.6 Operational Definitions of Variables 
Dependent variable 
The participant´s oxygen saturation was measured using digital handheld pulse 
oximeter. Three readings were recorded and the highest value was used as the best 
pulse oximetry value. The values were further classified into normal and lower : 
Lower: <SpO2 95% 
Normal: >SpO2 95% 
Independent variables 
Baseline demographic characteristics: age, sex, measurements, self-reported cardiac 
diseases, self-reported respiratory diseases, grading of breathlessness and smoking 
were measured. 
All men and women aged 40 years or more visiting a GP office of the doctor 
participating in the study self-recorded their age. After filling in the questionnaire, and 
rested for at least 15 minutes, the health personnel measured the arterial oxy-
hemoglobin saturation of patients with a digital handheld pulse oximeter. Three 
measurements with intervals of 1 minute were recorded and the best one was used in 
the analyses. Then height (without shoes), and weight (in light clothing) were 
recorded. Body Mass Index (BMI) was categorized according to World Health 
Organisation (WHO) criteria as normal, overweight and obese if BMI <25 kg/m2, 
BMI = (25-29.99) kg/m2 and BMI  ≥30 kg/m2 respectively. 
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The participants themselves recorded any presence of myocardial infarction, arterial 
hypertension, and any other heart diseases. These were included as self-reported 
cardiac diseases. The participants recording presence of asthma, COPD, respiratory 
infection, chronic lung diseases were included as self-reported respiratory diseases. 
Self-reported breathlessness was classified as none, moderate and severe 
breathlessness categories. Smoking habits were reported as: never, ex-smoker, and 
current smoker.  
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2. Methodology 
2.1 Study Design 
 Descriptive cross-sectional study 
2.2 Study Site  
Data collected from GP offices in Northern Norway and Northwest Russia. In Russia, 
the data were collected in the cities of Arkhangelsk and Murmansk and in the offices 
placed in the rural areas of Arkhangelsk region. 
2.3 Study Population 
All men and women aged 40 years or more visiting GP offices of the doctor who 
voluntarily participated in the study. 
2.4. Sampling Technique 
All men and women aged 40 years or more visiting a GP office of the doctor 
participating in the study. 
2.5 Sample Size  
The prevalence of low SpO2 levels (≤95%) was expected about 10% and 12-14%, in 
the Norwegian and Russian samples respectively. The primary interest represents the 
subgroup of patients with known COPD, which was assumed to comprise around of 
10% in both samples. Thus, initially, it was planned to recruit 2000 Norwegians and 
2000 Russians so that it could report 200 participants with known COPD in each 
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country. However, it was not possible practically to recruit 2000 Norwegian samples 
thus we adjusted the sample size with 618 samples from Norwegian group and 3215 
samples from Russian group.  
2.6 Exclusion and Inclusion Criteria 
GP population who were less than 40 years old and did not want to respond to the 
questionnaire were excluded. 
2.7 Instrumentation 
Questionnaire:  Participants were asked to fill in a one-page questionnaire while 
he/she was waiting for admission to the doctor. 
Physical examination: Health personnel examined the patient. The height (without 
shoes), and weight (in light clothing) were measured. The arterial oxyhemoglobin 
saturation and pulse were measured with a digital handheld pulse oximeter.  
2.8 Data Collection Tools 
Techniques:  Respondents were asked to read through a short information letter on 
the study's aim and methodology and then to think over the proposal for 10-15 
minutes, returning of the fulfilled questionnaire was considered as agreement to 
participate. After filling up the questionnaire, and resting for at least 15 minutes, the 
health personnel measured arterial oxyhemoglobin saturation with a handheld pulse 
oximeter.  
Tools: A structured questionnaire was used for the data collection. A digital handheld 
pulse oximeter was used for measuring SpO2 and Pulse. Physical examination was 
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done to measure height, weight and waist circumference. BMI was calculated with 
the formula (46):   𝐵𝑀𝐼 = weight(𝑘𝑔)
[ℎ𝑒𝑖𝑔ℎ𝑡(ℎ)]2
 
2.9 Data Analysis  
The information collected from the respondents were sorted, coded and entered in 
datasheet created in a statistical package for Social Science (SPSS) version 23. Data 
from Norway and Russia was merged. Differences between nationalities (Norway and 
Russia) and gender (men and women) were tested using chi-square and Independent 
Sample t-test for categorical and continuous explanatory variables, respectively. The 
association between independent variables and oxygen saturation were assessed using 
binary logistic regression and was reported as odds ratio (OR) with 95% confidence 
interval (CI). The dependent variable, oxygen saturation was assigned the value 0 and 
1. Low oxygen saturation (SpO2) with the value SpO2 <95% was coded 0 and normal 
oxygen saturation with the value SpO2 >95% was coded 1.  
First, the association of independent variables and oxygen saturation was measured in 
an unadjusted univariate model.  Multivariate logistic regression was conducted. The 
variables adjusted in the final model for multivariate logistic regression was obtained 
using backward elimination (wald method). The criterion for statistical significance 
was p ≤0.05. 
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2.10 Ethical Aspects 
The application was considered by Regional Committee for Medical and Health 
Research Ethics (REK south-east) in the meeting 22/08/2013. The assessment was 
made pursuant to the Health Research Act (hfl.)10, ref. Ethics Act 4 project Review. 
Pursuant to the Health Research Act 9 ref. 33 approved the committee. Participants 
received an information sheet without consent form and completing the questionnaire 
was considered sufficient consent. Participants were ensured to maintain the 
confidentiality. 
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3. Study Findings 
3.1 Demographic and baseline characteristics of the respondents  
3.1.1 Demographic and baseline characteristics of respondents in Northern 
Norway and Northwest Russia 
The descriptive study was conducted in Northern Norway and Northwest Russia. 
Altogether there were 3833 respondents, 618 from Norway and 3215 from Russia. 
The comparison and significant difference between two nationalities: Norway and 
Russia as per explanatory variables are summarised in Table 1.  
Out of 3833 respondents, the majority were from Russia (83.9%). The mean age in 
Norway and Russia were 58.6 years and 60.4 years respectively (p-value = 0.001). In 
Norway, majority of the respondents (27.9%) were from age group (40-49) years, 
26.4% were from age group (50-59) years, 25.2% were from the age group (60-69) 
years, 16. 5 % were from age group (70-79) years, and few 4 % were from 80 years 
and above age group. However, in Russia, the majority (29%) were from age groups 
(50-59) years, followed by 27.9% in age groups of (60-69) years, 18.9% in (40-49) 
years age groups, 17.4% in (70-79) years and 5.9% in 80 years and above. The 
number of female respondents was more in both Norway and Russia, 55.5% and 
63.7% (p-value <0.001). Mean pulse rate in Norway and Russia were 70.7 
beats/minute (bpm) and 72.5 bpm respectively. The majority of the respondents had a 
normal pulse rate (60-100) bpm both in Norway (76%) and Russia (88.1%) (p-value 
<0.001). The mean body mass index in Northern Norway and Northwest Russia were 
28.1 kg/m2 and 28.5 kg/m2 respectively (p-value <0.001). The proportion of 
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overweight; BMI > (25- 29.9) kg/m2 was 42.7% and obesity (BMI >30 kg/m2) was 
26.2% in Norwegian respondents. In Russia, the proportion of overweight and obesity 
was 36.4% and 36.6% respectively (p-value <0.001).  
Among the self-reported cardiac diseases, arterial hypertension was found more 
common cardiac diseases in both countries with its prevalence rate of 31.1% and 
69.8% in Norway and Russia respectively (p-value <0.001). The prevalence of MI in 
Norway and Russia was 4.7% and 9.4% respectively (p-value <0.001). Similarly, 
among self-reported respiratory diseases, asthma, and respiratory infection were more 
common respiratory problems found both in Norway and Russia. In Norway, 10.8% 
respondents had asthma while it was 6.1% in Russia (p-value <0.001). Overall, 46.8% 
respondents in Norway reported breathlessness problems; among them, 4.2% reported 
severe difficulty in breathing. Likewise, in Russia, 51.7% reported breathlessness, 
among them 4.1% reported severe difficulty in breathing.  In Norway, the majority of 
people were ex-smoker (43.8%). In contrary, the majority of Russian respondents 
never smoked (63.7%). In both countries, the proportion of current smokers were 
almost similar i.e, 18.3% and 18.9% in Norway and Russia respectively. 
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Table 1: Baseline characteristics of respondents as per nationality (Norway and 
Russia) 
Factors Norway n (%) Russia n (%) p-value 
Valid n (%) 618 (100.0) 3215 (100.0)  
Age, years, mean (SD)  58.6 (11.8) 60.4 (11.6)   0.001 
Age, years (cat)   <0.001 
40-49 166 (27.9) 608 (18.9)  
50-59 157 (26.4) 958 (29.8)  
60-69 150 (25.2) 898 (27.9)  
70-79 98 (16.5) 561 (17.4)  
80 above 24 (4.0) 190 (5.9)  
Total  595 (96.3) 3215 (100.0)  
Gender   <0.001 
Male  272 (44.5) 1168 (36.3)  
Female 339 (55.5) 2047(63.7)  
Total  611(98.9) 3215 (100.0)  
Measurements    
Pulse rate, bpm, mean (SD)  70.7 (14.0) 72.56 (11.4)   0.004 
Pulse rate, bpm   <0.001 
<60  131(21.2) 315 (9.8)  
60-100  469 (76.0) 2834 (88.1)  
 >100  17 (2.8) 66 (2.1)  
Total  617 (99.8) 3215 (100.0)  
BMI kg/m2 , mean  (SD) 28.1 (14.1) 28.5 (5.4) <0.001 
BMI kg/m2 (cat)   <0.001 
<25  188 (31.0) 852 (26.9)  
<25- 29.9) 259 (42.7) 1152 (36.4)  
>30  159 (26.2) 1158 (36.6)  
Total  606 (98.1) 3162 (98.4)  
SpO2, mean (SD) 97.7 (1.2) 97.9 (1.4) <0.001 
SpO2, % (cat)     0.074 
SpO2 <95  27 (4.4) 96 (3.0)  
SpO2 >95 591(95.6) 3119 (97.0)  
Self-reported cardiac diseases 
MI  28 (4.7) 303 (9.4) <0.001 
Total  593 (96.0) 3213 (99.9)  
Arterial hypertension  186 (31.1) 2241 (69.8) <0.001 
Total  599 (96.9) 3212 (99.9)  
Other heart diseases 56 (9.1) 386 (12.0)   0.071 
Total  594 (96.1) 3214 (100.0)  
Table to be continued in next page 
  
20 
 
Table 1 continued 
Factors Norway n (%) Russia n (%) p-value 
 
Self-reported respiratory diseases 
Asthma  65 (10.8) 197 (6.1) <0.001 
Total  602 (97.4) 3204 (99.7)  
COPD  30 (5.0) 207 (6.4) 0.178 
Total  600 (97.1) 3211 (99.9)  
Respiratory infection  57 (9.5) 280 (8.7) 0.509 
Total  597 (96.6) 3214 (100.0)  
Chronic lung diseases  14 (2.3) 126 (3.9) 0.061 
Total  596 (96.4) 3214(100.0)  
Self-reported breathlessness 0.054 
None  291 (53.7) 1152 (48.3)  
Moderate  228 (42.1) 1531 (47.6)  
Severe  23 (4.2) 132 (4.1)  
Total  542 (87.7) 3215 (100.0)  
Smoking Habit   <0.001 
Never smokers  232 (37.9) 2048 (63.7)  
Ex-smokers  268 (43.8) 559 (17.4)  
Current smokers  112 (18.3) 607 (18.9)  
Total  612 (99.0) 3214 (100.0)  
 
Values are mean with standard deviation (SD) or number n with percentage of column (%); 
BMI (Body Mass Index); SpO2 (Oxygen Saturation); bpm (beats per minute); MI (myocardial 
infarction); COPD (Chronic Obstructive Pulmonary Disease); 1 Calculated by Pearson’s chi – 
squared test and Independent Sample t-test 
 
 
 
Figure 1: Prevalence of lower oxygen saturation based on nationalities 
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Figure 1 demonstrates the image about the prevalence of lower oxygen saturation in 
Northern Norway and Northwest Russia. The low oxygen saturation is prevalent 
higher in Northern Norway compared to Northwest Russia, ie, 4.4% and 3.0% 
respectively. 
3.1.1.2 Baseline characteristics of men and women in the study population  
Table 2 presents the baseline characteristics of the study population by men and 
women. The descriptive study conducted in Norway and Russia constitutes 3833 
participants among which 3826 participants responded to their gender. Female 
constituted the majority in number 2386 (62.4%) of which 85.8% female participants 
were Russian. The mean age was 60.4 years for men and 59.9 years for female (p-
value <0.001).  
The Smoking habit was more prevalent among men than women. However, the 
prevalence of obesity (BMI >30 kg/m2) was higher in women than men. The lower 
oxygen saturation <95% was prevalent more in men in comparison to female. 
Similarly, cardiovascular diseases like MI and respiratory diseases like COPD, 
chronic lung diseases were prevalent more in men than women.   
The Majority in (83.5%) men and women (87.8%) had normal pulse rate; (60-100) 
bpm (p-value <0.001). The mean body mass index was 27.7 kg/m2 for men and 28.9 
kg/m2 for women (p-value <0.001). The prevalence of overweight was higher in men 
(39.3%) in comparison to women (36.3%). However, the proportion of obesity was 
higher in women (37.8%) in comparison to men (30.2%) (p-value <0.001). The mean 
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oxygen saturation (SpO2) was 97.7% for men and 97.9% for women (p-value <0.001). 
The prevalence of lower oxygen saturation is higher in men (4.9%) than women 
(2.2%) (p-value <0.001). Moreover, among the self-reported cardiac diseases, arterial 
hypertension was the most common cardiac disease prevalent both in men and 
women, which was respectively 61.8% and 64.9% (p-value = 0.056). Myocardial 
infarction was prevalent more in men (14.6%) than women (5.1%) (p-value <0.001). 
Similarly, among self-reported respiratory diseases, 10.5% men and 3.6% women (p-
value <0.001) had COPD. Likewise, chronic lung’s diseases were present among 
4.7% men and 3.0% women. The majority of the men were involved in the smoking 
habit in comparison to women. Among them, 36.8% men and 12.4% women were ex-
smokers. While the proportion of current smokers among men and women was 32.0% 
and 10.8% respectively (p-value <0.001). 
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Table 2: Baseline characteristics of men and women in the study population  
Factors Men n (%) Women  n (%)     P1 
Total valid  1440  2386   
Nationality    
Norway 272 (18.9) 339 (14.2) <0.001    
Russia 1168 (81.1) 2047 (85.8)  
Age, years, mean (SD) 60.4 (11.5) 59.97 (11.7) <0.001 
Age, years (cat)     0.019 
40-49 282 (19.7) 492 (20.7)  
50-59 387 (27.0) 726 (30.5)  
60-69 437 (30.5) 611 (25.7)  
70-79 246 (17.2) 413 (17.4)  
80 above 79 (5.5) 135 (5.7)  
Measurement    
Pulse rate, bpm, mean 
(SD)  
72.1 (12.6) 72.2 (11.4)  0.890 
Pulse rate, bpm (cat)    
<60  206 (14.3) 240 (10.1) <0.001 
60-100  1201 (83.5) 2096 (87.8)  
 >100  32 (2.2) 50 (2.1)  
BMI kg/m2 ( SD) 27.7 (5.01) 28.9 (8.7) <0.001 
BMI kg/m2 (cat)   <0.001 
<25  433 (30.6) 607 (25.9)  
= 25-29.9  556 (39.3) 852 (36.3)  
>30  427 (30.2) 886 (37.8)  
SpO2, %, mean  (SD) 97.7 (1.5) 97.9 (1.2) <0.001 
SpO2, % (cat)   <0.001 
 <95  70 (4.9) 52 (2.2)  
 >95  1370 (95.1) 2334 (97.8)  
Self-reported cardiac diseases 
MI 209 (14.6) 122 (5.1) <0.001 
Arterial hypertension  887 (61.8) 1537 (64.9)   0.056 
Other heart diseases 179 (12.5) 263 (11.1)   0.179 
Table to be continued in next page 
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Table 2 continued 
Factors Men n (%) Women  n (%)     P1 
 
Self-reported respiratory diseases 
Asthma  90 (6.3) 170 (7.2)   0.294 
COPD  150 (10.5) 86 (3.6) <0.001 
Respiratory infection 125 (8.7) 212 (8.9)   0.813 
Chronic lung diseases  67 (4.7) 72 (3.0)   0.009 
Self-reported breathlessness 
None  711 (50.5) 1129 (48.2)   0.367 
Moderate  638 (45.3) 1117 (47.7)  
Severe  58 (4.1) 97 (4.1)  
Smoking habit    
Never  449 (31.9) 1828 (76.8) <0.001 
Ex-smoker  529 (36.8) 295 (12.4)  
Current smoker  460 (32.0) 258 (10.8)  
 
Values are mean with standard deviation (SD) or number n with percentage of column (%); BMI 
(Body Mass Index); SpO2 (Oxygen Saturation); bpm (beats per minute); MI (Myocardial 
Infarction); COPD (Chronic Obstructive Pulmonary diseases); 1Calculated by Pearson’s chi–
squared test and Independent Sample t-test 
 
 
 
 
 
 
 
Figure 2: Proportion of lower oxygen saturation based on gender 
 
Figure 2 displays the comparative image of lower oxygen saturation prevalent among 
male and female subgroups. It demonstrates the presence of lower oxygen saturation 
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more in the males compared to the females. It is found to be 4.9% among male while 
2.2% among the female GP population. 
 
 
                              Figure 3: Age distribution according to gender 
 
Figure 3 shows the distribution of different age groups among male and female 
subjects. The majority of the men (30.5%) belonged to the age group of (60-69) years, 
while in female (30.5%) were from (50-59) years age group. Only a few participants 
in both groups belonged to the age category of 80 years and above. 
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3.2 Logistic Regression Analysis 
3.2.1 Association between independent variables and lower oxygen saturation 
among GP female populations. 
Table 3 presents the crude univariate analysis and (age) adjusted analysis of factors 
associated with lower oxygen saturation (normal/low: SpO2 >95%/SpO2 <95%) 
among GP female population of adults. The univariate analysis was performed with 
only a single independent variable included in the model at a time.  
Among the GPs´ female population, the independent variables associated with lower 
oxygen saturation (p-value <0.05) were age, BMI, self-reported cardiac diseases- 
(other heart diseases, arterial hypertension), self-reported respiratory diseases - 
(COPD, asthma, chronic lung diseases), and self-reported - breathlessness (severe). 
The crude analysis in women population revealed statistically significant association 
between age and oxygen saturation. It showed the odds of having lower oxygen 
saturation increased with increasing age (OR = 1.04; 95% CI = 1.01-1.07). In 
univariate analysis, age group (51-60) years (OR = 2.9; 95% CI = 0.9-8.7), (71-80) 
years (OR = 3.6; 95% CI = 1.1-11.4) and 80 and above years (OR = 8.7; 95% CI = 
2.6-28.7) were significantly associated with the lower oxygen saturation level.  
Although in crude unadjusted analysis there was not significant association with 
lower oxygen saturation and BMI, however, adjusting the factor age, a significant 
association was observed between oxygen saturation level and BMI. Adjusting the 
factor age showed the odds of lower oxygen saturation increased with increasing BMI 
(OR = 1.01; 95% CI = 1.00-1.02). Also, according to self-reported cardiac disease, the 
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presence of heart diseases revealed the association with lower oxygen saturation (OR 
= 2.2; 95% CI = 1.1-4.2). Similarly, among self-reported respiratory diseases, COPD 
and lower oxygen saturation had a significant association with each other (OR = 10.1; 
95% CI = 5.2- 19.7). The odds of having lower oxygen saturation among those having 
chronic lung diseases was three times that of those without chronic lung diseases 
problems (OR = 3.3; 95% CI = 1.2-8.6). Similarly, women presented with asthma also 
had 3 times risk of having lower oxygen saturation. Likewise, the odds of having 
lower oxygen saturation among those reporting severe breathlessness problem was 4.4 
times that of those without any breathlessness problems (reference group). Thus, 
severe breathlessness was significantly associated with the lower oxygen saturation 
level (OR = 4.4; 95% CI = 1.7-11.5).  
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Table 3: Univariate and age-adjusted analysis: Risk factors for lower oxygen 
saturation among female GP population 
 
Determinants  
Unadjusted Adjusted for age 
OR  (95 % CI) p* OR (95% CI) p** 
Nationality     
Norway (ref ) 1.0  1.0  
Russia 0.7 (0.3-1.6) 0.518 0.6 (0.3-1.4) 0.321 
Age, years  1.04 (1.01-1.06) 0.001 -  
Age, years (cat)   -  
40-50 (ref) 1.0    
51-60  2.9 (0.9-8.7) 0.055   
61- 70 2.0 (0.6-6.5) 0.234   
71- 80 3.6 (1.1-11.4) 0.026   
Above 80  8.7 (2.6-28.7) <0.000   
Pulse rate , bpm 1.0 (0.9-1.0) 0.146 1.0 (0.9-1.0) 0.145 
Pulse rate, bpm (cat)  
<60 (ref) 1.0  1.0  
= 60-100  0.6 (0.3-1.5 ) 0.383 0.6 (0.3-1.5) 0.386 
 >100  1.3 (0.2-6.8) 0.689 1.4 (0.2-7.0) 0.671 
BMI, kg/m2 1.01(0.99-1.02) 0.066 1.01 (1.00-1.02) 0.029 
BMI, (cat)     
<25 (ref) 1.0  1.0  
< 25- 29.9  0.9 (0.4-2.0) 0.806 0.7 (0.3-1.7) 0.580 
>30  1.6 (0.8-3.3) 0.175 1.4 (0.7-3.0) 0.292 
Self-Reported cardiac diseases 
MI     
No (ref)  1.0  1.0  
Yes  1.5 (0.5-4.3) 0.405 1.1 (0.3-3.0) 0.899 
Arterial Hypertension     
No (ref)  1.0  1.0  
Yes  0.8 (0.4-1.5) 0.610 0.5 (0.2-0.9) 0.041 
Other heart diseases    
No (ref)  1.0  1.0  
Yes  2.7 (1.4-5.2) 0.002 2.2 (1.1-4.2) 0.017 
Table to be continued in next page 
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Table 3 continued 
 
Determinants  
Unadjusted for age Adjusted for age 
OR  (95 % CI) p* OR  (95 % CI) p** 
Self-reported respiratory diseases 
Asthma      
 
No (ref)  1.0  1.0  
Yes  3.2 (1.5-6.5) 0.001 3.2 (1.5-6.5)  0.001 
COPD      
No (ref)  1.0  1.0  
Yes  11.4 (5.9-22.1) <0.001 10.1 (5.2-19.7) <0.001 
Respiratory Infection   
No (ref)  1.0  1.0  
Yes  1.3 (0.5-3.1) 0.508 1.5 (0.6-3.6) 0.329 
Chronic lung diseases   
No (ref)  1.0  1.0  
Yes  3.5 (1.3-9.2) 0.009 3.3 (1.2-8.6) 0.014 
Self-reported breathlessness 
None (ref) 1.0  1.0  
Mild 1.5 (0.8-2.9)   0.150 1.2 (0.6-2.4) 0.471 
Severe 7.1 (3.0-16.5) <0.001 4.4 (1.7-11.5) 0.002 
Smoking habit     
Never (ref) 1.0  1.0  
Ex-smoker                    0.5 (0.2-1.6)     0.332 0.7 (0.2-2.1) 0.627 
Current smoker 1.2 (0.5-2.7)    0.638 1.7 (0.7-4.2) 0.178 
 
OR (Odd Ratio); (ref) reference group; CI (confidence interval); BMI (Body Mass Index), COPD 
(Chronic Obstructive Pulmonary Disease); SpO2 (Oxygen Saturation); bpm (beats per minute); MI 
(Myocardial Infraction); * (crude); ** (adjusted for age) 
 
 
 
3.2.2 Association between independent variables and lower oxygen saturation 
among GP male populations. 
Table 4 summarizes the result of crude analysis and the result adjusted with age factor 
among GP male population. The analysis in men showed- age, pulse rate, self-
reported cardiac diseases-arterial hypertension other heart diseases, self- reported 
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respiratory disease- COPD, self-reported breathlessness and current smoking habit as 
a statistically significant associative factors with oxygen saturation.  
There was a significant association between lower oxygen saturation and age (OR = 
1.05; 95% CI = 1.02-1.07). In univariate analysis, age group (51-60) years (OR = 
14.5; 95% CI = 1.9-109.0), (60-70) years (OR = 14.1; 95% CI = 1.8-106.0), (70-80) 
years (OR = 24.8; 95% CI = 3.3-186.7) and 80 and above years (OR = 31.6; 95% CI = 
3.8-257.2) were significantly associated with the lower oxygen saturation level.  
With every unit rise in pulse rate, the odds of having lower oxygen saturation 
increased by 1.02 times (OR = 1.02; 95% CI = 1.01-1.04). According to self-reported 
cardiac disease, presence of heart diseases indicated the association with lower 
oxygen saturation (OR = 1.9; 95% CI = 1.1-3.5). Among self-reported respiratory 
diseases, COPD showed statistical significant association with lower oxygen 
saturation (OR = 2.7; 95% CI = 1.5-4.9). The trend of having lower oxygen saturation 
among those reporting breathlessness problem increased with increase in intensity. 
The odds of having lower oxygen satuartion among those reporting mild 
breathlessness problem was almost twice (OR = 2.1; 95% CI = 1.1-3.9) and those 
reporting severe breathlessness problems was 7.1 times that of those without any 
breathlessness problems (reference group). The odds of having lower oxygen 
saturation among the current smokers was 4.0 times that of the nonsmokers, who 
never smoked (OR = 4.0; 95% CI = 2.0-8.0). 
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Table 4: Univariate and age-adjusted analysis: Risk factors for lower oxygen 
saturation among GP male population  
Determinants  Unadjusted Adjusted for age 
OR  (95% CI) p* OR (95% CI) p** 
Nationality     
Norway (ref) 1.0  1.0  
Russia 0.7 (0.4-1.2) 0.239 0.7 (0.3-1.2) 0.242 
Age, years  1.05 (1.02-1.07) <0.001 -  
Age, years (cat)   -  
40-50 (ref) 1.0  -  
51-60  14.5 (1.9-109.0) 0.009 -  
61- 70 14.1 (1.8-106.0) 0.010 -  
71- 80 24.8 (3.3-186.7) 0.002 -  
80 above 31.6 (3.8-257.2) 0.001   
Measurements     
Pulse rate , bpm 1.02 (1.01-1.04) 0.011 1.02 (1.01-1.04) 0.005 
Pulse rate, bpm (cat)  
<60 (ref) 1.0  1.0  
60-100  1.3 (0.6-2.8) 0.464 1.4 (0.7-3.2) 0.297 
 >100  0.7 (0.1-6.6) 0.835 0.8 (0.1-7.2) 0.892 
BMI, kg/m2 1.0 (0.9-1.0) 0.253 1.0 (0.9-1.0) 0.221 
BMI, kg/m2 (cat)     
<25.0  (ref) 1.0  1.0  
<25.0-29.9  0.6 (0.3-1.2) 0.253 0.6 (0.3-1.2) 0.225 
>30.0  1.2 (0.7-2.2) 0.433 1.2 (0.7-2.2) 0.435 
Self-reported cardiac diseases 
MI     
No (ref)  1.0  1.0  
Yes  1.1 (0.5-2.1) 0.790 0.7 (0.3-1.5) 0.464 
Arterial hypertension  
No (ref)  1.0  1.0  
Yes  1.8 (1.5-3.2) 0.030 1.2 (0.6-2.1) 0.502 
Other heart diseases 
No (ref)  1.0  1.0  
Yes  2.5 (1.4-4.5) 0.001 1.9 (1.1-3.4) 0.024 
Self-reported respiratory diseases 
Asthma      
No (ref)  1.0  1.0  
Yes  2.0 (0.9-4.3) 0.075 1.7 (0.7-3.7) 0.177 
COPD      
No (ref)  1.0  1.0  
Yes  3.3 (2.0-6.1) <0.001 2.7 (1.5-4.9) <0.001 
Table to be continued in next page  
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Table 4 continued 
Determinants  Unadjusted Adjusted for age 
OR  (95% CI) p* OR (95% CI) p** 
 
Respiratory infection  
No (ref)  1.0  1.0  
Yes  1.3 (0.6-2.9) 0.411 1.6 (0.7-3.6) 0.182 
Chronic lung diseases  
No (ref)  1.0  1.0  
Yes  1.9 (0.8-4.7) 0.121 2.0 (0.8-4.8) 0.123 
Self-reported breathlessness 
None (ref) 1.0  1.0  
Mild 2.5 (1.4-4.5)  0.001 2.1 (1.1-3.9) 0.012 
Severe 10.0 (4.5-22.1) <0.001 7.1 (3.0-16.6) <0.001 
Smoking habit     
Never (ref) 1.0  1.0  
Ex-smoker  1.5 (0.8-3.1) 0.184 1.4 (0.7-2.9) 0.263 
Current smoker 2.5 (1.3-4.9) 0.004 4.0 (2.0-8.0) <0.001 
 
OR (Odd ratio); (ref) reference group; CI (Confidence Interval); BMI (Body Mass Index), COPD 
(Chronic Obstructive Pulmonary Disease); SpO2 (Oxygen Saturation); bpm (beats per minute); 
*(unadjusted p-value); ** (adjusted for age) 
 
 
3.2.3 Multivariate logistic regression analysis: An association between 
independent variables and lower oxygen saturation among male and female GP 
population 
Table 5 summarises the multivariate analysis among male and female GPs population. 
Multivariate analysis was performed with the significant predictors observed through 
backward (wald) method. Nationality, age, gender, self-reported cardiac diseases – 
other heart diseases, self-reported respiratory diseases- COPD, self-reported 
breathlessness, and smoking habit were adjusted in multivariate regression analysis. 
The factors- age, BMI, and COPD were included in multivariate analysis in men as 
priori. In the women, as priori, age and smoking variables were also added for 
multivariate analysis. 
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According to the multivariate analysis in table 5, the association between oxygen 
saturation level and nationalities was statistically significant in male population. The 
prevalence of lower oxygen saturation among the Russian participants was less 
compared to the participants from Norway (OR = 0.3; 95% CI = 0.1-0.7). Moreover, 
the odds of lower oxygen saturation among men increased with increasing pulse rate 
(OR = 1.02; 95% CI = 1.01-1.04). 
According to self-reported cardiac disease, the presence of other heart diseases 
revealed the association with lower oxygen saturation in both male and female. The 
odds of having lower oxygen saturation among men and women with other heart 
diseases was two times more than those without other heart diseases. The odds of 
having lower oxygen saturation among female with arterial hypertension was 0.3 
times that of the female with no arterial hypertension. Similarly, among self-reported 
respiratory diseases, the odds of having lower oxygen saturation among COPD female 
was 8.8 times than that without COPD. 
In addition, the odds of having lower oxygen saturation among men with self-reported 
breathlessness is 3.6 times then that without breathlessness problem. Current smoking 
habit had an association with lower oxygen saturation in men (OR = 3.5; 95% CI = 
1.6-7.3). However, multivariate analysis in the women does not show a statistical 
significant association between smoking habits and lower oxygen saturation. 
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Table 5: Multivariate adjusted odds ratio estimates for lower oxygen saturation with 
95% confidence interval  among male and female GP population 
 
Factors 
Men  Women  
Multivariatea p-value  Multivariateb p-value 
Adjusted  
OR (95% CI) 
 Adjusted  
OR (95% CI) 
 
Nationality     
Norway (ref) 1.0  -  
Russia 0.3 (0.1-0.7) 0.003 -  
Age, years  1.03 (0.93-1.13) 0.511 1.03 (0.93-1.14) 0.485 
Age, years (cat) 
40-50 (ref) 1.0  1.0  
51-60  9.64 (1.04-89.34) 0.046 2.3 (0.4-10.7) 0.289 
61-70  6.8 (0.4-102.4) 0.162 1.2 (0.1-12.0) 0.859 
71-80  8.5 (0.2-256.3) 0.214 1.7 (0.07-39.7) 0.738 
Above 80  11.0 (0.1-778.4) 0.269 2.8 (0.1-170.0) 0.614 
Pulse measurement, bpm 1.02 (1.01-1.04) 0.012 -  
BMI 1.0 (1.0-1.1) 0.155 1.01(1.01-1.03) 0.006 
Self-reported cardiac diseases 
Arterial hypertension -    
No (ref) -  1.0  
Yes  -  0.3 (0.1-0.7) 0.007 
Other heart diseases 
No (ref)  1.0  1.0  
Yes  1.9 (1.1-3.5) 0.035 2.09 (1.03-4.21) 0.040 
Self-reported respiratory diseases 
Asthma -    
No -  1.0  
Yes -  2.0 (0.9-4.5) 0.078 
COPD      
No (ref)  1.0  1.0  
Yes  1.6 (0.8-3.1) 0.118 8.8 (4.2-18.8) <0.001 
Self–reported breathlessness 
None (ref)   -  
Mild 1.6 (0.8-3.0) 0.114 -  
Severe 3.6 (1.4-9.2) 0.007 -  
Smoking habit     
Never (ref) 1.0  1.0  
Ex-smoker  1.1 (0.5-2.3) 0.749 0.3 (0.1-1.2) 0.111 
Current smoker  3.5 (1.6-7.3) 0.001 1.2 (0.5-3.0) 0.643 
 
aAdjusted for nationality, age in years (continuous), age in years (categorical), pulse 
measurement, BMI, self-reported cardiac diseases-other heart diseases, self-reported respiratory 
diseases-COPD, self-reported breathlessness, smoking; b Adjusted for age in years (continuous), 
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age in years (categorical), BMI, self-reported cardiac diseases-arterial hypertension, other heart 
diseases, self-reported respiratory diseases- asthma, COPD, smoking; OR (Odd Ratio); ref 
(reference group); CI (Confidence Interval); COPD (Chronic Obstructive Pulmonary Disease); 
SPO2 (Oxygen Saturation); bpm (Beats per minute); BMI (Body Mass Index) 
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4. Discussion 
4.1 Methodological Consideration 
4.1.1 Selection bias 
The comparison between two countries may vary because of their difference in socio-
economic status, mortality, co-morbidity, and the distribution of prevalence of several 
chronic diseases (47). Non-participants and participants might be different (47). The 
result can be generalized in Scandinavian countries (47); yet, the generalization to the 
entire world is questionable because of the sample number and the site limitation in 
Northern Norway and Northwest Russia.  
4.1.2 Information bias  
It can be introduced as a result of measurement error in the assessment of both 
exposure and diseases (48). In our study, some variables were obtained from the self-
reported questionnaire thus recall bias could exist which might influence the 
sensitivity and/or specificity of the questions. The data can be misclassified, leading 
to a nondifferential error. Moreover, answers to the stigmatized condition or habits, 
sometimes can be misleading. The answers towards smoking habit could be 
controversial. But our questionnaire was self-reporting, anonymous and answers were 
straightforward; limited to- ex-smoker, current smoker and never smoked. Thus, the 
results might not be misleading.  
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4.1.3 Measurement errors  
The sensitivity and specificity may differ between different ranges of the scale that 
leads to a differential error (49). In this study, weight and height were measured and 
BMI was calculated. In addition, SpO2 and pulse were measured in resting subjects 
using pulse oximetry. Thus, measurements done in participants are valid. However, 
there are conditions which result in false SpO2 reading; either lower or  higher (50). 
For example, overestimation in darkly pigmented skin (51). Also, nail polish , dirt, 
artificial nails, and bright artificial light can cause falsely low readings or no readings 
(14). Additionally, carbon monoxide poisoning can result in inadequate oxygen 
transport despite normal pulse oximeter readings (14). Likewise, certain antiretroviral 
medications affect oxygen affinity for haemoglobin (52). Also, normal oxygen 
saturation levels in older patients may be slightly lower than in younger people (14). 
In addition, the presence of COHb in chronic heavy smokers (53, 54), and high 
glycohemoglobin (HbA1c) level in people with type 2 diabetes may also overestimate 
SpO2 (55). There could be overestimated readings in heavy smokers and high COHb, 
or in people with type 2 diabetes and high HbA1c level . 
4.1.4 Confounding  
Confounding is extraneous factor/ variable which distort the association between the 
exposure and disease of interest or the effect of the exposure of interest to the disease 
is distorted because of the extraneous factor (48). It is possible to control by 
randomization and matching while designing the study or by stratification, or by 
statistical modelling during analysis stage (56). Also, there is a possibility of 
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occurring type I error (false –positive) with an increase in the number of statistical 
analysis and can be solved by lowering the significance level. Similarly, type II error 
(false-negative) can occur with the increasing number statistical hypothesis testing 
which can be minimised by increasing the power of the study (57).  
In this study, stratification was done to explore the differences between men and 
women; in addition, age was adjusted while doing logistic regression. Men and 
women had different SpO2 values (higher in men), even after adjusting for other 
known factors. Moreover, backward elimination (wald) was used to select variables to 
include in the final model for multivariate logistic regression. Known priori was also 
adjusted during multivariate analysis. 
4.1.5 Statistical power and validity 
The sample was taken from 40 years and above which reflects the general adult 
population in Northern Norway and Northwest Russia. The population is similar to 
the Norwegian population or other Caucasian northern European populations with 
respect to age and sex distribution or the prevalence of risk factors (58, 59). Hence, 
the results could be applicable to similar Caucasian northern European populations 
(47). The participation rate was high (more than 95%) and thus internally valid. 
However, external validity, the degree to what the result of a study is applicable to 
another population (48), ability to generalize with another population is questionable 
because of the limitation of subjects within in Northern part of Norway and Northwest 
Russia. 
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4.2 Findings 
According to this study, the lower oxygen saturation, SpO2 ≤95%; measured at a 
single-point measurement with pulse oximetry was associated with nationality, age, 
gender, self-reported cardiac diseases-other heart diseases, self-reported respiratory 
diseases-COPD, self-reported breathlessness in the severe stage and current smoking 
habit.  
We observed the distribution of lower oxygen saturation prevalent more among the 
Norwegian group (4.4%) compared to Russian (3.0%). The distribution of lower 
oxygen saturation is quite parallel with the Tromso study (2005/07) presenting the 
prevalence of decreased SpO2 to be 4.9% among the subjects. Similarly, a cross-
sectional population-based survey performed in Tromsø, Norway, in 2007-2008 
showed the prevalence of SpO2 ≤95% as 6.3%. 
The main reason for such difference in the Norwegian and Russian groups is due to a 
higher percentage of subjects in Norwegian group involving in the smoking habit 
(former and current smokers) compared to the Russian group ie, almost twice times 
higher rate in Norwegian group. In addition, the difference in health care system 
could be another possible reason for the difference in comorbidity among GP 
Populations in two countries. In Russia, usually, the patients with chronic diseases 
and low SpO2 are treated by a specialist in the out patient departments 
(pulmonologists, cardiologist). Thus, the prevalence observed in Russian groups is 
underestimated or under-represented. However, the situation in Norway is inverse; 
GPs are responsible for treating chronically ill patients. The baseline characteristics in 
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our study had also shown the unhealthier group higher among Norwegian GP 
populations.  
Further, the risk factors present with age accelerate lower oxygen saturation level. 
Ageing could be associated with physiological changes and increasing comorbidity. 
Consequently, it can be difficult to assess all confounding factors related to age in 
multivariable analyses (47).  
As per this study, smoking was associated with low SpO2. Smoking is associated with 
the development of emphysema, COPD, and chronic lung diseases which is 
responsible for lower oxygen saturation. Current smoking habit in men had shown a 
significant association with low SpO2 (27). 
The prevalence of lower oxygen saturation was twice times more in male GP 
population compared to the female population in the study. The disparity in the 
distribution of risk factors such as co-morbidity, lifestyle pattern, and smoking habits 
can be the reason for this difference. The study showed that almost three-fourth of 
men were involved in smoking habits; almost twice times more than female GP 
populations. In addition, the presence of self-reported cardiac diseases and self-
reported respiratory disease was common more among male compared to female 
subjects. Thus, it indicates that the male population attending general practitioners 
were unhealthier compared to female. 
There was an association between BMI and lower oxygen saturation only in female 
groups. Correspondingly, the presence of COPD in female presented eight folds more 
risk of having lower oxygen saturation.  Surprisingly, the study exhibited the risk of 
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having lower oxygen saturation among female with arterial hypertension as almost 
half that of the female with no arterial hypertension due to the unknown confounding 
factors. 
Similarly, the male population of Russia showed almost half the risk of having lower 
oxygen saturation compared to Norwegian male. Likewise, in men, increase in pulse 
rate showed statistical significance with lower oxygen saturation. Also, the presence 
of self-reported breathlessness showed four times more risk of having lower oxygen 
saturation among the male population. The current smoking habit showed thrice times 
the risk of having lower oxygen saturation in the male GP populations.  
A cross-sectional population-based survey performed in Tromsø, Norway, in 2007-
2008, showed the similar pattern of result which showed with BMI, increased age, 
male gender, and smoking (p-value <0.001) as the predictor variables. 
4.3 Strength of the Study 
x It is the comparative study showing the prevalence of lower oxygen saturation in 
Norway and Russia. 
x This study tests the association between variables and lower oxygen saturation.  
x It provides plans for advanced statistical analysis 
x It represents a pilot project, trying to create a network of scientifically engaged 
general practitioners in Arkhangelsk and Murmansk regions in Russia to ensure 
their participation in more complicated and ambitious data collections in the 
future.  
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4.3 Limitation of the Study 
x The study may not represent the overall situation throughout the world. 
x Measurement error, recall bias, selection bias as explained above in 
methodological consideration parts. 
x In general, Russian GP population are “healthier” than Norwegian GP population 
as most of the chronically ill patients in Russia are treated by the specialist only. 
Thus, the prevalence observed in Russian groups is the underestimation and under 
representative.  
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5. Conclusion  
In conclusion, the lower oxygen was prevalent more in Northern Norway compared to 
Northwest Russia. Similarly, the proportion of lower oxygen saturation is present 
more among male groups compared to female groups. According to this study, lower 
oxygen saturation was related to gender, pulse rate, BMI, self-reported heart diseases, 
self-reported COPD, self-reported chronic and current smoking habit. Adjusting for 
confounders, a statistically significant predictor of lower oxygen saturation was self-
reported cardiac disease, which was significant both in male and female groups. In 
men, self-reported breathlessness in severe stage, and current smoking habit showed 
statistically significant association with lower oxygen saturation. While in women, 
BMI and COPD were predictive factors associated with oxygen saturation. 
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6. Recommendation 
Pulse oximetry is easy, safe, convenient and useful in risk assessment. It helps in 
providing some level of risk stratification and the findings can be used to evaluate 
further. Being a simple and valid screening test, the use of pulse oximetry in general 
practice is recommended. 
Despite the wide potentials of pulse oximetry in primary care settings, there are only a 
few researches reported about the usage and application. Moreover, the information 
about low oxygen saturation and its association with mortality or morbidity in a 
general population is limited. Hence, it is also recommended to conduct more research 
on the application of pulse oximetry in nearby future. 
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Appendix III: POMOR Project  
Since 1998 the NPUC has been accumulating an experience to administrate 
Norwegian-Russian joint projects and to act as a project manager and financial 
manager, contact link, communication link and arena for projects realization with 
Norwegian and Russian co-partners. 
The topic of social interaction received increasing attention to public debates in 
both countries that time. The social sphere development was not in a focus of Russian 
politicians that time, meanwhile the transformation of economics and lifestyles 
resulting from the reforming altered the conditions shaping world social sphere. A 
number of factors influenced an appearance of a new international project in the field 
of social work between Arkhangelsk and Bodo in 1998: 
 Transformation of social sphere in Russia and in Arkhangelsk region; 
 Availability of funds for Norwegian-Russian cooperation: Cooperation 
Program with Central and Eastern Europe in the field of higher education and 
research, Barents Secretariat; 
 Mutual interest on behalf of researchers and staff on a institutional level in 
both countries; 
 Accumulated experience within international projects by Russian and 
Norwegian universities 
The project started in 1998 and turned out with a long-term cooperation between 
Arkhangelsk and Bodo: 
 Pomor I 1998-2001 Participants: Bodo University College, Faculty of social 
sciences 
 Pomor II 2001-2002 Pomor State University, Faculty of social work 
 Pomor III 2002-2006 Norwegian-Pomor University Centre 
The Pomor I took as its point of departure the objectives: 
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 to accomplish a program of institution-building at the faculty of social work, 
Pomor State University, and the Norwegian-Pomor University Centre in 
Arkhangelsk; 
 to accomplish a program for improving and qualifying social work students in 
Bodo and Arkhangelsk; 
 to strengthen the international perspectives of both institutions and develop 
democratic and human values in social work education. 
The intention of the first Pomor project was students and staff exchange, 
conferences on various themes connected to the field of social work, curriculum and 
study program development, video-conferences, translation and editing of literature, 
development of comparative research projects. 
The second Pomor project was closely related to the penalty system, and 
developing methods and programs for social workers in the penitentiary system. 
The third cooperation project - the Pomor III that started in 2002 - continued 
previous activities. Over the past four years the Pomor III indicated major activities of 
research, education, de-centralized courses, training programs, translation and 
publishing books and paper collections, thematic excursions, seminars and 
conferences on such contemporary problems as prevention work on criminality and 
substance abuse, prevention work with child protection and family welfare, violence 
against women, mediation, democratization of social institutions, penitentiary system 
and NGO-s. 
The development of the Pomor III worked out with a variety of forums and 
disseminated in various ways. Discussions have taken place in working meetings, 
seminars and international conferences. Publications included books, collections of 
contributions and articles. In addition, a series of thematic manuals and handbooks 
examining a number of central issues within the project, have been released during the 
process. 
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In May 2004 Arkhangelsk welcomed over 80 people to the international 
conference "Prevention strategies in social work". The conference became the crucial 
meeting within the project by providing an opportunity for Russian and Norwegian 
researchers, teachers and practical social workers to present their views to an audience 
of prevention strategies from social work perspective. The conference obtained to 
better understanding of the role of prevention work and disseminated among practical 
workers and academicians those strategies that would enhance local services and 
social work and social policy education development. 
During the period of 2002-2005 a series of seminars have been held in 
Arkhangelsk. The seminars provided practical social workers, administrators from 
social sphere and academicians with knowledge and new approaches on mediation, 
penalty system and empowerment. 
By means of cooperation with Mediation Board in Trondheim and thanks to 
enthusiasm and experience of Iren Sorfjordmo, the leader of Konfliktradet in 
Trondheim, about 20 Russians - officers of social services from Arkhangelsk - have 
got Norwegian diplomas as mediators. The program that based on learning an 
experience of Mediation Boards in Norway seems to be essential and useful for 
Russian environment where social situation hardly could be called as a stable one, and 
where courts are overloaded by administrative offences. 
Mikaela Bengtsson from Sweden did much for the project development in 2002-
2003 in democratization and prevention within penitentiary system aspect. The 
Brattsbrytet program led by Mikaela involved prison officers from Arkhangelsk and 
Murmansk, who were to learn new approaches and to get todays' competence on a 
penalty system development and rehabilitation of inmates. Implementation of the 
program in several colonies and prisons in Arkhangelsk county was a success. 
Helping people in solving life problems by means of empowerment has received 
increasing attention in the program "VINN" (Victory"). The project has been initiated 
jointly by Norwegian Ministry of Justice and educational centre KRUS from Oslo. 
Torunn Hojdahl and Marna Storksen have been the leaders for the TOT (training of 
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trainers) seminar in Arkhangelsk and shared knowledge with Russian participants on 
empowerment strategies. 
The closing conference for the Pomor III was held in Bodo in June 2006. One of 
the most significant results of the conference and of the Pomor cooperation as well, as 
a sign of a really successful cooperation, was the establishing of a network where all 
members can continue to share ideas on relevant subjects, to cooperate directly 
person-to-person, to involve new members and to initiate new cooperation proposals. 
Such a network between Arkhangelsk and Bodo is a today's' reality. 
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